| pubmed-article:15950401 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15950401 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:15950401 | lifeskim:mentions | umls-concept:C0035412 | lld:lifeskim |
| pubmed-article:15950401 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15950401 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:15950401 | lifeskim:mentions | umls-concept:C0033727 | lld:lifeskim |
| pubmed-article:15950401 | lifeskim:mentions | umls-concept:C0086805 | lld:lifeskim |
| pubmed-article:15950401 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:15950401 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15950401 | pubmed:dateCreated | 2005-10-28 | lld:pubmed |
| pubmed-article:15950401 | pubmed:abstractText | Over 85% of pediatric orbital rhabdomyosarcoma (RMS) are cured with combined chemotherapy and radiation. However, the late effects of photon radiation compromise function and cosmetic outcome. Proton radiation can provide excellent tumor dose distributions while sparing normal tissues better than photon irradiation. | lld:pubmed |
| pubmed-article:15950401 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15950401 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15950401 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15950401 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15950401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15950401 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15950401 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:15950401 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:15950401 | pubmed:author | pubmed-author:TarbellNancyN | lld:pubmed |
| pubmed-article:15950401 | pubmed:author | pubmed-author:AdamsJudithJ | lld:pubmed |
| pubmed-article:15950401 | pubmed:author | pubmed-author:SchneiderRobe... | lld:pubmed |
| pubmed-article:15950401 | pubmed:author | pubmed-author:FriedmannAlis... | lld:pubmed |
| pubmed-article:15950401 | pubmed:author | pubmed-author:YockTorunnT | lld:pubmed |
| pubmed-article:15950401 | pubmed:author | pubmed-author:FullertonBarb... | lld:pubmed |
| pubmed-article:15950401 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15950401 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15950401 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:15950401 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15950401 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15950401 | pubmed:pagination | 1161-8 | lld:pubmed |
| pubmed-article:15950401 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:meshHeading | pubmed-meshheading:15950401... | lld:pubmed |
| pubmed-article:15950401 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15950401 | pubmed:articleTitle | Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. | lld:pubmed |
| pubmed-article:15950401 | pubmed:affiliation | Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. tyock@partners.org | lld:pubmed |
| pubmed-article:15950401 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15950401 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15950401 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15950401 | lld:pubmed |
